ER+Ve Breast Cancer by Amit Agarwal
Session 7 : ER+Ve Breast Cancer
Chairpersons :
Hemant Malhotra, Gurpreet Singh
Speaker :
Amit Agarwal
PALOMA-2: Primary results from a phase III trial of palbociclib (P) with letrozole (L) compared with letrozole alone in postmenopausal women with ER+/HER2- advanced breast cancer (ABC)
Author: Finn RS
Conference: 2016 ASCO Annual Meeting. Abstract 507 & N Engl J Med 2016 Nov17 ; 375(20):1925 1936
Impact of palbociclib plus letrozole on health related quality of life (HRQOL) compared with letrozole alone in treatment naive postmenopausal patients
Author: Hope rugo
Conference: 2016 ESMO 225 PD
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
Author: Gabriel Hortobagyi
Conference: 2016 ESMO LBA1 & N Engl J Med. 2016 Nov3 ;375(18):1738-1748
Biological effects of abemaciclib in a phase2 neoadjuvant study for postmenopausal patients with hormone receptor positive, HER2 negative breast cancer
Author: Hurvitz S
Conference: 2016 SABCS S4-06